Literature DB >> 11870140

Cytokine imbalance in pregnancies with fetal chromosomal abnormalities.

F Vesce1, C Scapoli, G Giovannini, L Tralli, G Gotti, A Valerio, A Piffanelli.   

Abstract

BACKGROUND: The aim of the present study is to investigate the levels of some of the cytokines which may be involved in the mechanisms leading to the impairment of placental perfusion and to the onset of uterine contractions in pregnancies with fetal genetic abnormalities compared with controls.
METHODS: The amniotic fluid and maternal plasma levels of interleukin-6, interleukin-8 and tumour necrosis factor-beta in patients with fetal chromosomal abnormalities were measured, as well as in euploid pregnancies in the seventh week of gestation.
RESULTS: An increase of interleukin-6 (P = 0.034) and a decrease of interleukin-8 (P < or =0.0001) in amniotic fluid, and a decrease of interleukin-6 in the maternal plasma (P = 0.026) was shown in pregnancies with fetal chromosomal abnormalities. A positive correlation was observed between amniotic interleukin-8 and serum interleukin-6 in the presence of fetal aneuploidy (P < 0.006).
CONCLUSION: Further investigations of cytokine imbalance in pregnancies with poor outcome as a consequence of genetic disorders rather than infection is warranted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870140     DOI: 10.1093/humrep/17.3.803

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome.

Authors:  Piotr Laudanski; Monika Zbucka-Kretowska; Karol Charkiewicz; Slawomir Wolczynski; Daniela Wojcik; Radoslaw Charkiewicz
Journal:  Mediators Inflamm       Date:  2014-11-16       Impact factor: 4.711

2.  Influence of vaginal lactoferrin administration on amniotic fluid cytokines and its role against inflammatory complications of pregnancy.

Authors:  Martina Maritati; Manola Comar; Nunzia Zanotta; Silva Seraceni; Alessandro Trentini; Fabrizio Corazza; Fortunato Vesce; Carlo Contini
Journal:  J Inflamm (Lond)       Date:  2017-02-15       Impact factor: 4.981

3.  Prenatal circulating microRNA signatures of foetal Down syndrome.

Authors:  Monika Zbucka-Kretowska; Magdalena Niemira; Magdalena Paczkowska-Abdulsalam; Agnieszka Bielska; Anna Szalkowska; Ewa Parfieniuk; Michal Ciborowski; Slawomir Wolczynski; Adam Kretowski
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

Review 4.  The Inflammatory Cytokine Imbalance for Miscarriage, Pregnancy Loss and COVID-19 Pneumonia.

Authors:  Fortunato Vesce; Chiara Battisti; Michele Crudo
Journal:  Front Immunol       Date:  2022-03-11       Impact factor: 7.561

Review 5.  Control of human trophoblast function.

Authors:  Laura Lunghi; Maria E Ferretti; Silvia Medici; Carla Biondi; Fortunato Vesce
Journal:  Reprod Biol Endocrinol       Date:  2007-02-08       Impact factor: 5.211

6.  Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.

Authors:  Karol Charkiewicz; Monika Zbucka-Kretowska; Joanna Goscik; Slawomir Wolczynski; Adam Lemancewicz; Piotr Laudanski
Journal:  J Immunol Res       Date:  2016-03-06       Impact factor: 4.818

7.  Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.

Authors:  Monika Zbucka-Kretowska; Karol Charkiewicz; Joanna Goscik; Slawomir Wolczynski; Piotr Laudanski
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.